Akzo Nobel N.v.

Akzo N.v.

Martha Jacoba Willemse

Paulus Jacobus Sondermeijer

Paulus Jacobus Antonius Sondermeijer

Johannes A Claessens

Robin Wilson Morgan

Lesley Nicolson

The present invention is concerned with a Feline Herpesvirus (FHV) mutant comprising a heterologous gene or foreign DNA inserted into a section of the FHV genome. The invention also relates to a vector vaccine comprising a recombinant FHV mutant which expresses a heterologous polypeptide derived from a feline pathogen and a pharmaceutically acceptable carrier and induces an immune response in an inoculated host against both FHV and the feline pathogen.

Vector vaccine of recombinant feline herpesvirus

The present invention is concerned with a Feline herpesvirus (FHV) mutant comprising a heterologous gene introduced into an insertion-region of the FHV genome. The invention also relates to a vector vaccine comprising such an FHV mutant which expresses a heterologous polypeptide derived from a feline pathogen and induces an adequate immune response in an inoculated host against both FHV and the feline pathogen.

Recombinant feline herpesvirus vaccine

The present invention relates to an Equine herpesvirus (EHV) vaccine comprising an EHV having an insertion or deletion in the gene 15 of the EHV genome.

Equine herpesvirus gene 15 mutants

The invention is concerned with the MD18 and MD20 polypeptides of Marek's Disease virus which can be used to vaccinate poultry against MD. The invention also relates to nucleic acid sequences encoding the MD18 or MD20 polypeptides. Said sequences can be used for the preparation of a subunit or vector vaccine.

Growing community of inventors

Nijmegen, Netherlands

Martha Jacoba Willemse